Trial · NCT04423718
Adverse events1,944
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,944
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Cataract | Eye disorders | Aflibercept 2q8 (Week 0- 96) | 22 | 336 | 22 |
| other | Cataract | Eye disorders | Aflibercept HDq12 (Week 0- 96) | 29 | 335 | 29 |
| other | Cataract | Eye disorders | Aflibercept HDq16 (Week 0- 96) | 32 | 338 | 33 |
| other | Cataract | Eye disorders | All Aflibercept HD (Week 0- 96) | 61 | 673 | 62 |
| other | Cataract | Eye disorders | Aflibercept 2q8/HD (Week 0- 156) | 27 | 208 | 29 |
| other | Cataract | Eye disorders | Aflibercept HDq12 (Week 0- 156) | 34 | 210 | 37 |
| other | Cataract | Eye disorders | Aflibercept HDq16 (Week 0- 156) | 33 | 207 | 35 |
| other | Cataract | Eye disorders | All Aflibercept HD (Week 0- 156) | 67 | 417 | 72 |
| other | Retinal haemorrhage | Eye disorders | Aflibercept 2q8 (Week 0- 96) | 19 | 336 | 21 |
| other | Retinal haemorrhage | Eye disorders | Aflibercept HDq12 (Week 0- 96) | 16 | 335 | 16 |
| other | Retinal haemorrhage | Eye disorders | Aflibercept HDq16 (Week 0- 96) | 17 | 338 | 20 |
| other | Retinal haemorrhage | Eye disorders | All Aflibercept HD (Week 0- 96) | 33 | 673 | 36 |
| other | Retinal haemorrhage | Eye disorders | Aflibercept 2q8/HD (Week 0- 156) | 17 | 208 | 22 |
| other | Retinal haemorrhage | Eye disorders | Aflibercept HDq12 (Week 0- 156) | 11 | 210 | 11 |
| other | Retinal haemorrhage | Eye disorders | Aflibercept HDq16 (Week 0- 156) | 11 | 207 | 15 |
| other | Retinal haemorrhage | Eye disorders | All Aflibercept HD (Week 0- 156) | 22 | 417 | 26 |
| other | Visual acuity reduced | Eye disorders | Aflibercept 2q8 (Week 0- 96) | 24 | 336 | 31 |
| other | Visual acuity reduced | Eye disorders | Aflibercept HDq12 (Week 0- 96) | 21 | 335 | 24 |
| other | Visual acuity reduced | Eye disorders | Aflibercept HDq16 (Week 0- 96) | 23 | 338 | 34 |
| other | Visual acuity reduced | Eye disorders | All Aflibercept HD (Week 0- 96) | 44 | 673 | 58 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04423718/events